Skip to content
Screener
Biote Corp. logo

Biote Corp.

BTMD

Biote Corp. operates a high-growth practice-building platform within the hormone optimization space, utilizing a model similar to a franchise to empower medical practitioners.

Market cap
$33.55M-63.4%
Revenue$183.5M-7.8%
Net income$5.9M-81.3%
Free cash flow$19.9M-42.9%
EPS (diluted)$0.11-87.9%
Trailing twelve months · change vs. prior year

Earnings

Q2 2026 report

August 5, 2026
Revenue$44.2MMiss by $1.9MEPS-$0.23Miss by $0.26

Next report

Nov 4, 2026 (In 3 weeks)
Revenue estimate$44.0M
EPS estimate-$0.05

Financials

Q2 2026

Income statement

See full
Revenue$44.2M-9.5%
Gross profit$28.9M-17.3%
Operating income-$3.5M-133%
Net income-$6.6M-306%
EPS (diluted)-$0.23-330%

Balance sheet

See full
Cash & equivalents$11.2M-43.0%
Total debt$128.6M+19.2%
Total equity-$65.8M+22.7%
Total assets$101.7M-3.0%

Cash flow

See full
CapEx$2.6M+41.3%
Free cash flow-$3.7M-171%

Valuation & ratios

Valuation

See full
Market cap$33.55M-63.4%
Enterprise value$151.02M-10.6%
P/E5.7×+2.6×
P/S0.2×-0.3×

Profitability

See full
Gross margin68.6%-3.4pp
Operating margin8%-9.7pp
Net margin3.2%-12.5pp
FCF margin10.8%-6.7pp

Returns & leverage

See full
Current ratio1.4×+0.5×

Segments

By product

See full
Product Revenue$43.4M-9.0%
Pellet Procedures Product Revenue$30.3M-13.9%
Dietary Supplements$11.4M+5.7%
Disposable Trocars Product Revenue$1.2M-1.5%
Shipping Fees And Other Product Revenue$505.0K+6.5%

Competitors

By market cap

Walmart logo
Walmart$877.15B+8.1%
Target logo
Target$70.3B+73.7%
TEC
Bio-Techne Corp.$11.4B+21.8%
Impact BioMedical logo
Impact BioMedical$35.1M-46.3%
Briacell Therapeutics Corp. logo
Briacell Therapeutics Corp.$34.1M-53.4%
Biote Corp. logo
Biote Corp.$33.6M-63.0%
GT Biopharma logo
GT Biopharma$10.8M+302%
ELA
Elevai Labs, Inc.$2.5M-38.7%

By revenue growth

Walmart logo
Walmart+6.2%
Target logo
Target+2.0%
TEC
Bio-Techne Corp.-0.4%
Biote Corp. logo
Biote Corp.-7.8%

By net margin

TEC
Bio-Techne Corp.14.97%+4.2pp
Target logo
Target4.08%+0.4pp
Biote Corp. logo
Biote Corp.3.19%-12.5pp
Walmart logo
Walmart3.0%-0.1pp

Profile

Biote Corp. operates a high-growth practice-building platform within the hormone optimization space, utilizing a model similar to a franchise to empower medical practitioners. The company provides an end-to-end solution including clinical education, proprietary decision-support software, and inventory management tools to help clinics implement personalized bioidentical hormone replacement therapy. Additionally, the company develops and sells a complementary line of private-labeled dietary supplements to address physiological deficiencies in aging populations.

Competitive position

A leading provider in the hormone optimization market with a differentiated end-to-end platform and high practitioner retention rates.

GeographiesUnited States, Puerto Rico, Mexico, Dominican Republic
Customer segmentsMedical Practitioners, Aging Population, Menopausal Women, Andropausal Men
Business modelB2B2C, Practice-building platform, Direct-to-consumer e-commerce, Wholesale
Suppliers503B outsourcing facilities, Contract supplement manufacturers, Third-party logistics (3PL) providers, Medical supply manufacturers
CustomersMedical clinics, Independent healthcare practitioners, Retail patients
CountryUnited States of America
Listed2022
Employees194.0
CEORobert C. Peterson
SectorHealthcare
IndustryMedical - Care Facilities
Websitebiote.com
FilingsSEC EDGAR

FAQ

What is Biote Corp.'s market cap?
Biote Corp. (BTMD) has a market capitalization of $33.6M and trades on NASDAQ.
What is Biote Corp.'s revenue and profitability?
Biote Corp. generated $183.5M in trailing twelve-month revenue with net income of $5.9M, representing a net margin of 3.2%. Gross margin stands at 68.6%, with free cash flow of $19.9M. The latest reported period is Q2 2026.
Who are Biote Corp.'s competitors?
Biote Corp.'s key competitors include Walmart, Target, Impact BioMedical, Inc., and others. These companies compete in similar markets and product categories.
Who does Biote Corp. partner with?
Biote Corp.'s notable partners include AnazaoHealth Corporation, Right Value Drug Stores, LLC (Carie Boyd’s Prescription Shop), Medline Industries, LP, and others.
What subsidiaries does Biote Corp. have?
Biote Corp.'s subsidiaries include Asteria Health, BioSana ID LLC.
Where is Biote Corp. headquartered?
Biote Corp. is headquartered in United States of America and employs approximately 194 people. It has been publicly traded since 2022.